Non-small cell lung cancer (NSCLC) patients undergoing radical surgery exhibited a significant increase in sPD-L1 one month post-surgery, followed by a slight decrease at three months (14), suggesting a poor link to tumor removal. This evidence concerns the gene SPDL1 and non-small cell lung carcinoma.